Skip to main content

Phase-3 trials find 1-shot chikungunya vaccine safe: Lancet

The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.

from Times of India https://ift.tt/63wiNdL
via
Labels:

Comments

Post a Comment

Popular posts from this blog

Modi’s visit propels Gujarat BJP into election mode

Riding high on BJP’s wins in UP, Uttarakhand, Manipur and Goa, a jubilant PM Narendra Modi on Friday attributed the electoral victories to the power of democracy wherein people were voting for development. ​​​“Due to the power of democracy, BJP retained power in states where governments were hardly elected twice in a row. This was possible as people are voting for development,” Modi said at a gathering of over a lakh representatives from the state’s panchayati raj institutions. from Times of India https://ift.tt/E7GIhAx via
Post a Comment
Read more